Hainan Huluwa Pharmaceutical Group Co., Ltd. Share Price
Equities
605199
CNE100004223
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.26 CNY | -0.48% | -0.68% | -32.32% |
01/05 | Huluwa Pharmaceutical Gets Nod to Register Two Drugs | MT |
26/04 | Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 1.52B 209M 17.42B | Sales 2023 | 1.91B 263M 21.9B | Capitalization | 6.07B 836M 69.73B |
---|---|---|---|---|---|
Net income 2022 | 85M 11.71M 977M | Net income 2023 | 106M 14.61M 1.22B | EV / Sales 2022 | 4.37 x |
Net Debt 2022 | 204M 28.06M 2.34B | Net Debt 2023 | 759M 105M 8.72B | EV / Sales 2023 | 3.58 x |
P/E ratio 2022 |
76.3
x | P/E ratio 2023 |
56.1
x | Employees | 2,468 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.88% |
1 day | -0.48% | ||
1 week | -0.68% | ||
Current month | -7.90% | ||
1 month | -13.27% | ||
3 months | -19.97% | ||
6 months | -35.67% | ||
Current year | -32.32% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 01/07/01 |
Peng Xu
CHM | Chairman | 61 | 01/10/01 |
Hui Yu
DFI | Director of Finance/CFO | 40 | 08/22/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gui Hua Wang
BRD | Director/Board Member | 63 | 16/18/16 |
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 01/07/01 |
Ping Liu
BRD | Director/Board Member | 51 | 01/12/01 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 10.26 | -0.48% | 964,800 |
14/24/14 | 10.31 | -0.67% | 1,217,800 |
13/24/13 | 10.38 | -1.89% | 1,430,400 |
12/24/12 | 10.58 | +1.93% | 1,770,103 |
End-of-day quote Shanghai S.E., June 17, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-32.32% | 566M | |
+51.82% | 797B | |
+40.58% | 628B | |
-6.88% | 351B | |
+16.95% | 323B | |
+9.49% | 300B | |
+17.04% | 244B | |
+0.90% | 223B | |
+5.30% | 163B | |
-6.29% | 153B |
- Stock Market
- Equities
- 605199 Stock